US regulator rejects Lykos’s MDMA therapy, wants more data
Lykos Therapeutics’s ecstasy drug or midomafetamine capsules for the treatment of post-traumatic stress disorder in adults was rejected by the US drug regulatory.
Drugs
Health
Pharma
Drugs
Health
Medical
Adolescent stress alters brain gene expression, leading to behavioral issues
HQ Team February 3, 2024: New research from the University of São Paulo’s Ribeirão Preto Medical School suggests that excessive stress during adolescence.